R&D Systems™ Recombinant Human CMG-2/ANTXR2 Fc Chimera Protein

Catalog No.	Quantity
10-360-AR050	50 μg

Catalog No. 10-360-AR050 Supplier R&D Systems™ Supplier No. 10360AR050

Description

Measured by its binding ability in a functional ELISA.

When Anthrax Protective Antigen is immobilized at 1.5 μg/mL (100 μL/well), it binds Recombinant Human CMG-2/ANTXR2 Fc Chimera (Catalog # 10360-AR) with an ED50 of 1-6 ng/mL.

Specifications

• Accession Number: P58335
• Formulation: Lyophilized from a 0.2 μm filtered solution in PBS.
• Gene ID (Entrez): 118429
• Molecular Weight (g/mol): Observed: 55-75 kDa, under reducing conditions; Theroretical: 57 kDa
• Quantity: 50 μg
• Source: Human embryonic kidney cell, HEK293-derived human CMG-2/ANTXR2 protein Human CMG-2/ANTXR2 (Gln34-Asn317) Accession # P58335.5(N-terminus) IEGRMD Human IgG1 (Pro100-Lys330) (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20°C to -70°C as supplied. 1 month, 2°C to 8°C under sterile conditions after reconstitution. 3 months, -20°C to -70°C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU / 1 μg of the protein by the LAL method.
• Conjugate: Unconjugated
• Reconstitution: Reconstitute at 500 μg/mL in PBS.
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.
• Protein: CMG-2/ANTXR2